MENU
+Compare
BMXMF
Stock ticker: OTC
AS OF
Aug 8 closing price
Price
$149.14
Change
+$4.94 (+3.43%)
Capitalization
17.17B

BMXMF Biomerieux 69 Marcy L'Etoile Forecast, Technical & Fundamental Analysis

BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination... Show more

BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BMXMF with price predictions
Aug 08, 2025

BMXMF in upward trend: price rose above 50-day moving average on July 25, 2025

BMXMF moved above its 50-day moving average on July 25, 2025 date and that indicates a change from a downward trend to an upward trend. In of 29 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BMXMF just turned positive on July 29, 2025. Looking at past instances where BMXMF's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where BMXMF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMXMF as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMXMF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BMXMF broke above its upper Bollinger Band on July 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMXMF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.587) is normal, around the industry mean (8.160). P/E Ratio (35.136) is within average values for comparable stocks, (132.856). Projected Growth (PEG Ratio) (1.684) is also within normal values, averaging (1.738). Dividend Yield (0.007) settles around the average of (0.025) among similar stocks. P/S Ratio (3.817) is also within normal values, averaging (7.877).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMXMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

View a ticker or compare two or three
BMXMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

BMXMF paid dividends on June 08, 2021

Biomerieux 69 Marcy L'Etoile BMXMF Stock Dividends
А dividend of $0.62 per share was paid with a record date of June 08, 2021, and an ex-dividend date of June 04, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
Marcy l’Etoile
Phone
+33 478872000
Employees
13982
Web
http://www.biomerieux.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQB0.750.01
+1.28%
AquaBounty Technologies
AFG129.341.43
+1.12%
American Financial Group
CMCO13.90-0.26
-1.84%
Columbus McKinnon Corp
ADPT12.20-0.34
-2.71%
Adaptive Biotechnologies Corp
LVO0.61-0.03
-4.53%
LiveOne

BMXMF and Stocks

Correlation & Price change

A.I.dvisor tells us that BMXMF and COO have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMXMF and COO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMXMF
1D Price
Change %
BMXMF100%
+3.43%
COO - BMXMF
26%
Poorly correlated
+1.58%
SOAGY - BMXMF
24%
Poorly correlated
+1.10%
BRKR - BMXMF
22%
Poorly correlated
-2.34%
MGRM - BMXMF
21%
Poorly correlated
-0.74%
CHEOF - BMXMF
7%
Poorly correlated
N/A
More